Import-extort: what to make of Donald Trump’s titanic tariffs

Import-extort: what to make of Donald Trump’s...

Up next

Trailer: Boss Class Season 3

AI is changing how we work. It's turning us all into managers. Be a good one.The Economist’s management columnist, Andrew Palmer, takes on the bots in the third season of Boss Class. From cloning to coding, agents to entry-level jobs, he tackles the threat head on and figures out ...  Show more

Trailer: Boss Class Season 2

Good bosses are rare. They don’t have to be. The skills of management can be learned.


The Economist’s management columnist, Andrew Palmer, is here to help. The second season of Boss Class features leaders at some of the world’s best performing companies, fro ...

  Show more

Recommended Episodes

It could happen to you: introducing “Scam Inc”
Economist Podcasts

Our new podcast series is a shocking look at transnational organised crime: nearly as big as the illegal-drug trade and far more sophisticated than you might think. Beware. After a week that started with bold tariff moves by the Trump administration, what can be gleaned from how ...  Show more

Going gang-buster: we meet Ecuador’s president
Economist Podcasts

Yesterday’s arrest of a notorious gang leader is a win for Daniel Noboa. He assures our journalists he can beat back rampant transnational gangs without trampling democracy. The torrent of big geopolitical news has, perhaps surprisingly, not much moved the markets; we ask why. An ...  Show more

Scam Inc 2: Opportunity of a lifetime
Economist Podcasts

Who are the scammers? They aren't who you think. To listen to the full series, subscribe to Economist Podcasts+. If you’re already a subscriber to The Economist, you have full access to all our shows as part of your subscription. For more information about how to access Economist ...  Show more

Same news story: why Murdoch endures
Economist Podcasts

The all-famous Murdoch clan is engaged in a fierce battle over control of the family’s media companies. Our correspondent explains why turmoil at the top has not deterred investors. After decades of fruitless research into Alzheimer’s, there are finally some new drugs in the pipe ...  Show more